A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

July 15, 2022

Study Completion Date

July 15, 2022

Conditions
Chronic Kidney Disease
Interventions
DIAGNOSTIC_TEST

collection of serum/capillary creatinine values

collection of serum/capillary creatinine values

Trial Locations (25)

1115

Szent Imre Korhaz, Budapest, Budapest

8230

DRC Drug Research Ltd, Balatonfüred

10461

Kidney Medical Associates, PLLC, The Bronx

23320

Tidewater Kidney Specialists, Chesapeake

29306

DaVita Clinical Research (DCR) Spartanburg, Spartanburg

31904

Columbus Regional Research Institute, Columbus

33125

Med-Care Research, Miami

33183

International Research Associates, Miami

35805

Nephrology Consultants, LLC, Huntsville

40210

DaVita Clinical Research Germany GmbH, Düsseldorf

41009

Hospital Virgen Macarena, Seville

45136

InnoDiab Forschung GmbH, Essen

52511

DaVita Clinical Research Germany GmbH, Geilenkirchen

53226

DaVita Clinical Research, Wauwatosa

77054

DaVita Clinical Research, Houston

77384

DaVita Clinical Research, The Woodlands

78251

DaVita Clinical Research, San Antonio

79925

Davita Clinical Research, El Paso

89128

DaVita Clinical Research, Las Vegas

92392

Desert Cities Dialysis - Amethyst, Victorville

92395

Kidney & Hypertension Center, Victorville

06002

Davita Clinical Research-Hartford, Bloomfield

06762-2843

Nephrology & Hypertension Assoc., PC, Middlebury

55435-2129

DaVita Clinical Research, Edina

75402-6004

Sunbeam Clinical Research, Greenville

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04881448 - A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease | Biotech Hunter | Biotech Hunter